Literature DB >> 6848729

Surgicopathologic staging of neuroblastoma: prognostic significance of regional lymph node metastases.

F A Hayes, A Green, H O Hustu, M Kumar.   

Abstract

Of 254 children with neuroblastoma treated at St. Jude Children's Research Hospital, 102 (40%) had clinically localized tumors. Using a surgicopathologic staging system, 66 of these 102 children had localized tumor and 36 had tumor dissemination to regional lymph nodes. Survival of these two groups has been markedly different; 57 of 66 (87%) with localized tumor survive, compared with 11 of 35 (33%) with node dissemination, five of whom are less than two years from diagnosis. Our data indicate that the prognosis for children with neuroblastoma metastatic only to regional lymph nodes is no different from that of patients of similar age with widely disseminated tumor.

Entities:  

Mesh:

Year:  1983        PMID: 6848729     DOI: 10.1016/s0022-3476(83)80287-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  7 in total

Review 1.  Neuroblastoma.

Authors:  S Shah; Y Ravindranath
Journal:  Indian J Pediatr       Date:  1998 Sep-Oct       Impact factor: 1.967

Review 2.  Imaging of neuroblastoma: an overview.

Authors:  A Bousvaros; D R Kirks; H Grossman
Journal:  Pediatr Radiol       Date:  1986

Review 3.  Gene profiling of high risk neuroblastoma.

Authors:  Sanjeev A Vasudevan; Jed G Nuchtern; Jason M Shohet
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

4.  Prognostic value of different staging systems in neuroblastomas and completeness of tumour excision.

Authors:  N L Carlsen; I J Christensen; H Schroeder; P V Bro; U Hesselbjerg; K B Jensen; O H Nielsen
Journal:  Arch Dis Child       Date:  1986-09       Impact factor: 3.791

5.  Mechanism of direct spread of abdominal neuroblastoma: CT demonstration and clinical implications.

Authors:  M Oliphant; A S Berne
Journal:  Gastrointest Radiol       Date:  1987

6.  Allelic imbalance on chromosome 5q predicts long-term survival in neuroblastoma.

Authors:  S J Meltzer; S P O'Doherty; C N Frantz; K Smolinski; J Yin; A B Cantor; J Liu; M Valentine; G M Brodeur; P E Berg
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

7.  A phase II JN-I-10 efficacy study of IDRF-based surgical decisions and stepwise treatment intensification for patients with intermediate-risk neuroblastoma: a study protocol.

Authors:  Tomoko Iehara; Akihiro Yoneda; Atsushi Kikuta; Toshihiro Muraji; Kazuaki Tokiwa; Hideto Takahashi; Satoshi Teramukai; Tetsuya Takimoto; Shigeki Yagyu; Hajime Hosoi; Tatsuro Tajiri
Journal:  BMC Pediatr       Date:  2020-05-12       Impact factor: 2.125

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.